Adoption of New Methodology

Adoption of New Methodology 
We are continuously updating ourselves with new Quality Systems like QSA – Quality System Audits, ISO Quality Certifications and are ready to adopt the same for the benefit of our clients.

Mother-like caring attitude keeps our clients always smiling

Caring Attitude 
Being committed to the work and in our endeavor to give best of services, we look for better ways of handling products so that Pilferages / damages could be minimized, improve documentation processes to prevent willful malpractices in the system which is reason we have Internal Auditors who keep check on such practices.

Customized Solutions / Tailor made requirements to suite each Company 
Right from locating warehouse space – setting up infrastructure – sales tax / excise registrations – choosing / deputing / training manpower – Computer hardware / software installations – setting / customizing process / documentation / products flow – Inventory Management – Reporting. Everything is tailor made for the customer depending his own requirement and ready to adapt to changing environments.

Wide Network all over India 
We have over 50 well spread warehouses across India and ready to open offices in any part of India imparting professional nyc storage services and management is what being desired by the Companies today.

Pharmaceutical industry is recognized as knowledge based industry. Pharmaceuticals are medicinally effective chemicals, which are converted to dosage forms suitable for patients to imbibe. In its basic chemical form, pharmaceuticals are called bulk drugs and the final dosage forms are known as formulations.

A continuously grow-ing industry 

Pharmaceutical is a continuously growing industry. Rising population, new disease incidence or resurgence of certain diseases spurs the growth. In the 50 years since independence, the Indian pharmaceuticals industry has evolved significantly. Over 20,000 registered pharmaceutical manufacturers exist in the country. The market share of MNCs has fallen from 75% in 1971 to around 35% in 2000 while the share of Indian companies has increased from 20% in 1971 to nearly 65% in 2000.

Major domestic players namely Ranbaxy, Dr Reddy’s Labs, Cipla, Nicholas Piramal and Wockhardt are aggressively investing in R&D. Domestic players and MNCs have entered into marketing arrangements to increase market penetration and further strengthen positions in respective therapeutic segments

Leave a Reply

Your email address will not be published. Required fields are marked *